Cogent Biosciences, Inc.COGTNASDAQ
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank70
3Y CAGR+11.9%
5Y CAGR-4.4%
Year-over-Year Change
Year-over-year SG&A expense growth
3Y CAGR
+11.9%/yr
vs -13.3%/yr prior
5Y CAGR
-4.4%/yr
Recent acceleration
Acceleration
+25.2pp
Accelerating
Percentile
P70
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 46.91% |
| 2024 | 25.91% |
| 2023 | 31.14% |
| 2022 | 33.48% |
| 2021 | 12.72% |
| 2020 | 58.84% |
| 2019 | 47.14% |
| 2018 | 59.27% |
| 2017 | 36.32% |
| 2016 | 25.94% |